Ancora Advisors’s Anixa Biosciences ANIX Stock Holding History

Ancora Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.57K	Hold	1,275	–	–	﹤0.01%	1683
2026 Q1	$3.29K	Sell	1,275 -247	-16%	-$731	﹤0.01%	2060
2025 Q4	$4.75K	Hold	1,522	–	–	﹤0.01%	1973
2025 Q3	$5.02K	Hold	1,522	–	–	﹤0.01%	1498
2025 Q2	$5.02K	Hold	1,522	–	–	﹤0.01%	1488
2025 Q1	$4.35K	Hold	1,522	–	–	﹤0.01%	1445
2024 Q4	$3.53K	Hold	1,522	–	–	﹤0.01%	1507
2024 Q3	$4.79K	Hold	1,522	–	–	﹤0.01%	1456
2024 Q2	$3.36K	Hold	1,522	–	–	﹤0.01%	1502
2024 Q1	$4.75K	Hold	1,522	–	–	﹤0.01%	1445
2023 Q4	$5.91K	Hold	1,522	–	–	﹤0.01%	1374
2023 Q3	$4.98K	Hold	1,522	–	–	﹤0.01%	1389
2023 Q2	$4.87K	Hold	1,522	–	–	﹤0.01%	1388
2023 Q1	$6.54K	Hold	1,522	–	–	﹤0.01%	1359
2022 Q4	$6K	Sell	1,522 -500	-25%	-$2.4K	﹤0.01%	1436
2022 Q3	$10K	Hold	2,022	–	–	﹤0.01%	1479
2022 Q2	$6K	Buy	2,022 +1,522	+304%	+$4.8K	﹤0.01%	1703
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	2229
2021 Q4	$1K	Buy	+500	New	+$2.02K	﹤0.01%	2266

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Ancora Advisors's ANIX Position: Q2 2026 in Review

Ancora Advisors held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 1,275 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

Ancora Advisors first reported a position in ANIX in Q4 2021 and has held it in 19 quarters since. The position peaked at $10K in Q3 2022. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Ancora Advisors held 1,275 shares of Anixa Biosciences worth $3.57K as of Q2 2026.
Ancora Advisors left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1683 holding.
Ancora Advisors first reported a position in Anixa Biosciences in Q4 2021 and has held it in 19 quarters since.
Ancora Advisors's Anixa Biosciences position peaked at $10K in Q3 2022.
63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.